Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Weissman

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|February 22, 2001
Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trialN J Weissman, J A Panza, J F Tighe, et al.
Journal of the American College of Cardiology|December 10, 1999
Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatmentN J Weissman, J F Tighe, J S Gottdiener, et al.
American Heart Journal|December 1, 1995
Development of coronary compensatory enlargement in vivo: sequential assessments with intravascular ultrasoundN J Weissman, F O Mendelsohn, I F Palacios, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1996
Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanismsJ C Madsen, D H Sachs, J T Fallon, et al.
The American Journal of Medicine|May 1, 1987
Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacksN J Weissman, M K Shear, R Kramer-Fox, et al.
The New England Journal of Medicine|September 10, 1998
An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study GroupN J Weissman, J F Tighe, J S Gottdiener, et al.
Coronary Artery Disease|February 24, 2001
Sex differences in morphology of coronary artery plaque assessed by intravascular ultrasoundS E Sheifer, U K Arora, B J Gersh, et al.
Clinical Cardiology|January 1, 1995
Effect of hydration on cavity obliteration during dobutamine stress echocardiographyN J Weissman, S M Nidorf, A E Weyman, et al.
Journal of the American College of Cardiology|March 1, 1997
Effects of prolonging peak dobutamine dose during stress echocardiographyN J Weissman, G A Rose, G P Foster, et al.
The American Journal of Cardiology|November 15, 2000
Pathologic validation of a new method to quantify coronary calcific deposits in vivo using intravascular ultrasoundD S Scott, U K Arora, A Farb, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|February 22, 2001
Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trialN J Weissman, J A Panza, J F Tighe, et al.
Journal of the American College of Cardiology|December 10, 1999
Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatmentN J Weissman, J F Tighe, J S Gottdiener, et al.
American Heart Journal|December 1, 1995
Development of coronary compensatory enlargement in vivo: sequential assessments with intravascular ultrasoundN J Weissman, F O Mendelsohn, I F Palacios, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1996
Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanismsJ C Madsen, D H Sachs, J T Fallon, et al.
The American Journal of Medicine|May 1, 1987
Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacksN J Weissman, M K Shear, R Kramer-Fox, et al.
The New England Journal of Medicine|September 10, 1998
An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study GroupN J Weissman, J F Tighe, J S Gottdiener, et al.
Coronary Artery Disease|February 24, 2001
Sex differences in morphology of coronary artery plaque assessed by intravascular ultrasoundS E Sheifer, U K Arora, B J Gersh, et al.
Clinical Cardiology|January 1, 1995
Effect of hydration on cavity obliteration during dobutamine stress echocardiographyN J Weissman, S M Nidorf, A E Weyman, et al.
Journal of the American College of Cardiology|March 1, 1997
Effects of prolonging peak dobutamine dose during stress echocardiographyN J Weissman, G A Rose, G P Foster, et al.
The American Journal of Cardiology|November 15, 2000
Pathologic validation of a new method to quantify coronary calcific deposits in vivo using intravascular ultrasoundD S Scott, U K Arora, A Farb, et al.
Pageof 7